byetta glp-1 diabetes market impact North America Glucagon-Like Peptide-1 (GLP-1) Agonist GLP-1 trends 2025: real-world data,

For more information on Trulicitys clinical results and safety information, please read our past new now next in diatribe #69 or view the drug label

19 Comparison with SGLT-2 inhibitors Both GLP-1RAs and SGLT-2 inhibitors reduce all-cause and cardiovascular mortality

That's where a high-quality protein shake can help you stay consistent, especially on days when appetite is low or meal prep feels difficult

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease

Fiocruz-EMSs tech transfer stands as the first large-scale domestic biosimilar effort, aiming to undercut branded prices by up to 40%